文献速递神经肌肉病

定量肌肉MRI纳入面肩肱型肌营养不良症临床试验工具箱

Adding quantitative muscle MRI to the FSHD clinical trial toolbox.
PubMed 文献 · Neurology · 2017-10-13

该研究在140例经遗传和临床充分表征的FSHD1与FSHD2患者中,对腿部肌肉行定量MRI评估脂肪浸润和TIRM高信号,并与多项临床结局指标做相关性分析。结果显示,腿部总肌肉平均脂肪分数与运动功能量表、FSHD临床评分、Ricci评分及6分钟步行试验高度相关,且MRI可在腿部肌肉临床受累前检出肌肉病理。

要点

  • 定量腿部肌肉MRI与FSHD多项临床结局指标高度相关
  • MRI可在腿部肌肉临床无力出现前检出肌肉病理改变
  • 定量肌肉MRI是捕捉疾病严重度与运动功能的有前景生物标志物

核心结论

  • 定量肌肉MRI与临床结局指标高度相关,可在临床受累前检出腿部肌肉病理,是有前景的FSHD生物标志物,可纳入临床试验工具箱。

研究设计与样本

  • 研究纳入140例经遗传和临床充分表征、涵盖完整临床谱的FSHD1和FSHD2患者,评估腿部肌肉定量MRI的脂肪浸润与TIRM高信号,并与多项临床结局指标做相关性分析。

主要发现

  • 腿部总肌肉平均脂肪分数与运动功能量表、FSHD临床评分、Ricci评分、6分钟步行试验的相关系数分别为-0.845、0.835、0.791、-0.701。
  • 各肌群脂肪分数与相应肌力相关性良好,相关系数最高达-0.82。
  • 腘绳肌、内收肌、股直肌和腓肠肌内侧头最常受累,在疾病早期及无腿部肌无力患者中亦如此。
  • 20%的肌肉对呈不对称受累,肌肉内脂肪浸润自远端向近端递减3.9%。
  • 提示炎症的TIRM高信号见于3.5%的肌肉,伴或不伴脂肪浸润。

临床怎么用

  • 可将定量腿部肌肉MRI作为评估FSHD疾病严重度和运动功能的生物标志物纳入临床试验工具箱。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To add quantitative muscle MRI to the clinical trial toolbox for facioscapulohumeral muscular dystrophy (FSHD) by correlating it to clinical outcome measures in a large cohort of genetically and clinically well-characterized patients with FSHD comprising the entire clinical spectrum. METHODS: Quantitative MRI scans of leg muscles of 140 patients with FSHD1 and FSHD2 were assessed for fatty infiltration and TIRM hyperintensities and were correlated to multiple clinical outcome measures. RESULTS: The mean fat fraction of the total leg musculature correlated highly with the motor function measure, FSHD clinical score, Ricci score, and 6-minute walking test (correlation coefficients -0.845, 0.835, 0.791, -0.701, respectively). Fat fraction per muscle group correlated well with corresponding muscle strength (correlation coefficients up to -0.82). The hamstring muscles, adductor muscles, rectus femoris, and gastrocnemius medialis were affected most frequently, also in early stage disease and in patients without leg muscle weakness. Muscle involvement was asymmetric in 20% of all muscle pairs and fatty infiltration within muscles showed a decrease from distal to proximal of 3.9%. TIRM hyperintense areas, suggesting inflammation, were found in 3.5% of all muscles, with and without fatty infiltration. CONCLUSIONS: We show a strong correlation between quantitative muscle MRI and clinical outcome measures. Muscle MRI is able to detect muscle pathology before clinical involvement of the leg muscles. This indicates that quantitative leg muscle MRI is a promising biomarker that captures disease severity and motor functioning and can thus be included in the FSHD trial toolbox.

来源:Neurology,查看原文。版权归原作者所有。

引用

  1. Mul K, Vincenten SCC, Voermans NC, et al. Adding quantitative muscle MRI to the FSHD clinical trial toolbox. Neurology. 2017. PMID: 29030457. doi:10.1212/WNL.0000000000004647

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。